C M Bidwell & Associates LTD Merck & Co., Inc. Transaction History

C M Bidwell & Associates LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $285,246 - $318,277	-2,771 Reduced 68.37%	1,282 $136,000
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $1,748 - $2,242	-20 Reduced 0.49%	4,053 $449,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $39,644 - $44,536	-469 Reduced 10.33%	4,073 $351,000
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $101,189 - $114,703	1,212 Added 36.4%	4,542 $414,000
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $244,788 - $274,392	3,330 New	3,330 $273,000
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $264,779 - $301,288	-3,760 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $40,233 - $55,765	635 Added 20.32%	3,760 $289,000
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $5,896 - $6,653	-76 Reduced 2.37%	3,125 $284,000
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $97,838 - $106,647	1,286 Added 67.15%	3,201 $269,000
Q2 2019 Aug 07, 2019	BUY	$69.84 - $81.59 $101,966 - $119,121	1,460 Added 320.88%	1,915 $161,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $31,658 - $36,108	455 New	455 $38,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.